cytarabine has been researched along with vasoactive intestinal peptide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Astier, H; Nathanson, J; Pares-Herbute, N; Reichlin, S; Tapia-Arancibia, L | 1 |
| Bonilla, OM; Grider, JR | 1 |
| Abe, H; Honma, K; Honma, S; Katsuno, Y; Shinohara, K | 1 |
| Corazza, F; Harfi, I; Hayez, N; Lema-Kisoka, R; Sariban, E; Svoboda, M | 1 |
4 other study(ies) available for cytarabine and vasoactive intestinal peptide
| Article | Year |
|---|---|
Adenylate cyclase activation is not sufficient to stimulate somatostatin release from dispersed cerebral cortical and diencephalic cells in glia-free cultures.
Topics: 1-Methyl-3-isobutylxanthine; Adenylyl Cyclases; Animals; Calcium; Cells, Cultured; Cerebral Cortex; Colforsin; Cytarabine; Diencephalon; Immunohistochemistry; Neurons; Rats; Somatostatin; Time Factors; Vasoactive Intestinal Peptide | 1988 |
Differential expression of substance P, somatostatin, and VIP in neurons from cultured myenteric ganglia.
Topics: Animals; Culture Techniques; Cytarabine; Ganglia; Guinea Pigs; Myenteric Plexus; Neurons; Somatostatin; Stimulation, Chemical; Substance P; Vasoactive Intestinal Peptide | 1994 |
Two distinct oscillators in the rat suprachiasmatic nucleus in vitro.
Topics: Animals; Arginine Vasopressin; Circadian Rhythm; Cytarabine; Floxuridine; In Vitro Techniques; Mitosis; N-Methylaspartate; Rats; Rats, Wistar; Suprachiasmatic Nucleus; Vasoactive Intestinal Peptide | 1995 |
The neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) modulate several biochemical pathways in human leukemic myeloid cells.
Topics: Adenosine Triphosphate; Bromodeoxyuridine; Calcium; Cell Line, Tumor; Cyclic AMP; Cytarabine; Cytosol; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Interactions; Electrophoretic Mobility Shift Assay; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Estrenes; Flow Cytometry; Glycophorins; Humans; Immunosuppressive Agents; Inositol Phosphates; Intercellular Adhesion Molecule-1; Leukemia; Myeloid Cells; Neuropeptides; Pituitary Adenylate Cyclase-Activating Polypeptide; Protein Binding; Proto-Oncogene Proteins; Pyrrolidinones; Receptors, Vasoactive Intestinal Peptide; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tetradecanoylphorbol Acetate; Thrombin; Time Factors; Transcription Factor AP-1; Vasoactive Intestinal Peptide | 2004 |